Insider trade

Director exercised or converted 21K GDRX derivative securities

Traded Oct 26, 2025 · Filed Oct 27, 2025

Goodrx HoldingsGDRX

21K
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Oct 26, 2025
Reporting period: Not applicable
Filed with the SEC: Oct 27, 2025

DirectorOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001809519-25-000127

Filed / recorded

Oct 27, 2025, 9:54 PM UTC

Added to OQRO

Oct 7, 2026, 5:51 AM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

GoodRx Holdings, Inc.

Issuer CIK

1809519

Ticker

GDRX

Reporting person

Douglas Joseph Hirsch

Relationship

Director

Security

Restricted Stock Unit

Table

Derivative (Table II)

Transaction date

Oct 26, 2025

Transaction code

M

Shares / units

20,521

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

41,042

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on October 26, 2025, subject to continued service through the applicable vesting date.